Sona Establishes an At-The-Market Common Share Offering
Halifax, Nova Scotia--(Newsfile Corp. - April 9, 2021) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona")...
Day: April 9, 2021
Phyto Extractions(TM) (Adastra Labs) Launches New Shatter Product Line to Canadian Retail Market in Time for 420
LANGLEY, BC / Accesswire / April 9, 2021 / Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX)(Frankfurt:D2EP) ("Phyto Extractions™"...
Aptevo Therapeutics to Present at the American Association for Cancer Research Virtual Annual Meeting
SEATTLE, WA / ACCESSWIRE / April 9, 2021 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing...
TRxADE Group to Present at Planet MicroCap Showcase
CEO Suren Ajjarapu to Present Wednesday, April 21st, 2021 TAMPA, FL / ACCESSWIRE / April 9, 2021 / Trxade Group,...
Theralase Commences Collaborative Research with National Microbiology Laboratory for Development of Coronavirus Vaccine
TORONTO, ON / ACCESSWIRE / April 9, 2021 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
CureVac to Report Fourth Quarter and Full-Year 2020 Financial Results and Business Updates on April 15, 2021
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / April 9, 2021 / CureVac N.V. (Nasdaq:CVAC), a biopharmaceutical company developing a...
Syapse Showcases Real-World Mortality Data in American Society of Clinical Oncology’s JCO-CCI
Study validates Syapse’ Composite Mortality Score methodology and its ability to overcome disparities driven by social determinants of health in...
Turning Point Therapeutics Announces New Preclinical Data for Three Drug Candidates
Presentations Planned at Annual Meeting of American Association for Cancer Research, Held Virtually April 9-14SAN DIEGO, April 09, 2021 (GLOBE...
Sana Biotechnology Presents Preclinical Data at American Association for Cancer Research Annual Meeting 2021
– Targeted in vivo gene delivery of a CAR using a CD8-specific fusogenresults in tumor eradication –– Hypoimmune CAR T...
Philips showcases impact of tele-ultrasound advancing Precision Diagnosis at AIUM virtual event
Lumify with Reacts in Use_ICU April 9, 2021 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global...
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
TEL AVIV, Israel, April 09, 2021 (GLOBE NEWSWIRE) -- Vascular Biogenics Ltd. (“VBL Therapeutics” or the “Company”) (NASDAQ: VBLT), today...
ChemoCentryx’s Oral PD-L1 inhibitor, CCX559, Featured in Poster Presentation at the 2021 American Association for Cancer Research (AACR) Annual Meeting
-- CCX559 enhanced primary human T cell activity in vitro and demonstrated anti-tumor efficacy in two murine tumor models --...
Mersana Therapeutics to Host Conference Call and Webcast to Discuss the Selection of the NaPi2b Biomarker Cutoff and Commercial Diagnostic Development Path
Conference Call and webcast to be held on Friday, April 16, 2021, at 8:00 a.m. ETCAMBRIDGE, Mass., April 09, 2021...
Outset Medical Named a Winner in Round 2 of the KidneyX COVID-19 Kidney Care Challenge
Tablo Hemodialysis System recognized for its ease of use and remote-monitoring capabilities SAN JOSE, Calif.--(BUSINESS WIRE)--The U.S. Department of Health...
Novo Integrated Sciences Announces Pricing of $8.0 Million Registered Direct Offering
BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS--Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo Integrated Sciences”), a U.S.-based provider of multidisciplinary primary healthcare...
Outset Medical Announces Pricing of Primary and Upsized Secondary Public Offering
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the...
LUCIRA COVID-19 Test Kit Identifies Viral Variants
LUCIRA COVID-19 All-In-One Test Kit reactive to at least 99.9% of all known COVID-19 virus strains EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health,...
Love Hemp Group PLC Announces Directors Dealings and Extension of Broker Option
LONDON, ENGLAND / ACCESSWIRE / April 9, 2021 / Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), one of the...
Evotec And Exscientia Announce Start of Human Clinical Trials of Novel Immuno-Oncology Drug
SELECTIVE, NOVEL A2A RECEPTOR ANTAGONIST IS MOST ADVANCED ASSET ARISING FROM JOINT VENTURE BETWEEN EVOTEC AND EXSCIENTIA EXSCIENTIA TO LEAD...
Enhancement Center Hires Five New Therapists, Opens New Rio Rancho Location
The EC Team Adds to Their Numbers and Increases Mental Health Offerings Throughout the Pandemic ALBUQUERQUE, NM / ACCESSWIRE /...